Soy Consumption and Obesity

Dante Roccisano, Maciej Henneberg

Biological Anthropology and Comparative Anatomy Research Unit, School of Medical Sciences, University of Adelaide, Adelaide, Australia..

DOI: 10.4236/fns.2012.32038                

Abstract

Obesity is now present worldwide, including China, India and developing countries. It now seems no longer acceptable to argue that obesity can simply be explained in terms of caloric consumption only using simple concept of energy in and energy out. There may be specific causes of altered metabolism that produce nutritional imbalances. Individual variation in response to food intake may also be considered. Specific substances in the food chain can influence meta-bolism towards an increase in fat deposits. Xenoestrogens have been suggested to have such an influence. Soy contains phytoestrogens plus phytates, protease inhibitors and other anti-nutrients which block or compromise the body’s uptake of essential vitamins and minerals. This may contribute to nutritional anomalies. We analyzed data from WHO and FAO for 167 countries. These contained percentage of obese individuals (BMI > 30 kg/m2), GDP, caloric consump-tion per capita, and sugar and soy consumption per capita. Regressions and partial correlations were used. Soy con-sumption correlates significantly with levels of obesity, irrespective of GDP and caloric intake. For instance, poor Latin America with soy consumption of 28.9 kg/person/year has more obesity (18.4%) than better off European Union (14.1%) consuming 16.1 kg/person/year of soy. Soy consumption seems to contribute approximately 10% - 21% to the worldwide variation in obesity, depending on the method of statistical analysis. The ubiquitous presence of unfermented soy products in mass produced foods seems to be an important contributor to the obesity epidemic.

Keywords

Soy; Obesity; Anti-Nutrients; Diet; Metabolism; Phytoestrogens; Phytates

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	A. Basdevant and C. Ciangura, “Obesity, a Disease,” Bulletin de l’Académie Nationale de Médecine, Vol. 194, No. 1, 2010, pp. 13-20.
[2]	T. Wu, “Overweight and Obesity in China,” BMJ, Vol. 333, 2006, pp. 362-363. doi:10.1136/bmj.333.7564.362
[3]	S. W. Keith, et al., “Putative Contributors to the Secular Increase in Obesity: Exploring the Roads Less Traveled,” International Journal of Obesity, Vol. 30, 2006, pp. 15851594. doi:10.1038/sj.ijo.0803326
[4]	I. Rashad and M. Grossman, “The Economics of Obesity,” Public Interest, Vol. 156, 2004, pp. 104-112.
[5]	S. J. Salvy, A. Elmo, L. A. Nitecki, M. A. Kluczynski and J. N. Roemmich, “Influence of Parents and Friends on Children’s and Adolescents’ Food Intake and Food Selection,” American Society for Nutrition, Vol. 93, No. 1, 2011, pp. 87-92.
[6]	M. Henneberg and S. J. Ulijaszek, “Body Frame Dimensions Are Related to Obesity and Fatness,” American Journal of Human Biology, Vol. 12, No. 1, 2010, pp. 83-91. doi:10.1002/ajhb.20957
[7]	K. Szkudelska and L. Nogowski, “Genistein—A Dietary Compound Inducing Hormonal and Metabolic Changes,” J. Steroid Biochemistry & Molecular Biology, Vol. 105, No. 1-5, 2007, pp. 37-45. doi:10.1016/j.jsbmb.2007.01.005
[8]	B. Radovic, B. Mentrup and J. Kohrle, “Genistein and Other Soya Isoflavones Are Potent Ligands for Transthyretin in Serum and Cerebrospinal Fluid,” British Journal of Nutrition, Vol. 95, No. 6, 2006, pp. 1171-1176.
[9]	C. W. Xiao, “Health7 Effects of Soy Protein and Isoflavones in Humans,” Journal of Nutrition, Vol. 138, No. 6, 2008, pp. 1244S-1249S.
[10]	M. Penza, et al., “Genestein Affects Adipose Tissue Deposition in a Dose-Dependent and Gender-Specific Manner,” Endocrinology, Vol. 147, No. 12, 2006, pp. 57405751. doi:10.1210/en.2006-0365
[11]	B. D. Roebuck, “Trypsin Inhibitors Potential Concern for Humans?” Journal of Nutrition, Vol. 117, No. 2, 1987, pp.398-400.
[12]	J. R. Turnlund, J. C. King, W. R. Keyes, B. Gong and M. C. Michel, “A Stable Isotope Study of Zinc Absorption in Young Men: Effects of Phytate and a-Cellulose,” American Journal of Clinical Nutrition, Vol. 40, No. 5, 1984, pp. 1071-1077.
[13]	N. S. Shaw, C. J. Chin and W. H. Pan, “A Vegetarian Diet Rich in Soybean Products Compromises Iron Status in Young Students,” Journal of Nutrition, Vol. 125, No. 2, 1995, pp. 212-219.
[14]	M. J. Messina, “Legumes and Soybeans: Overview of Their Nutritional Profiles and Health Effects,” American Journal of Clinical Nutrition, Vol. 70, No. 3, 1999, pp. 439-450.
[15]	R. L. Divi and D. R. Doerge, “Inhibition of Thyroid Peroxidase by Dietary Flavonoids,” Chemical Research in Toxicology, Vol. 9, No. 1, 1996, pp. 16-23. doi:10.1021/tx950076m
[16]	D. R. Doerge, “Goitrogenic and Estrogenic Activity of Soy Isoflavones,” Environmental Health Perspectives, Vol. 110, Suppl. 3, 2002, pp. 349-353. doi:10.1289/ehp.02110s3349
[17]	R. B. Clarkson, M. S. Anthony and C. L. Hughes, “Estrogenic Soybean Isoflavones and Chronic Disease: Risks and Benefits,” Trends in Endocrinology & Metabolism, Vol. 6, No. 1, 1995, pp. 11-16. doi:10.1016/1043-2760(94)00087-K
[18]	W. A. Forsythe, “Soy Protein, Thyroid Regulation and Cholesterol Metabolism,” Journal of Nutrition, Vol. 125, Suppl. 3, 1995, pp. 619-623.
[19]	F. Balmir, et al., “An Extract of Soy Flour Influences Serum Cholesterol and Thyroid Hormones in Rats and Hamsters,” Journal of Nutrition, Vol. 126, No. 12, 1996, pp. 3046-3053.
[20]	K. S. H. Keim, “Glucose, Insulin, and Lipase Activity of Rats Fed Chromium from Beef and Soy,” PhD Thesis, Texas Tech University, Lubbock, 1983.
[21]	D. J. Appleton, J. S. Rand, G. D. Sunvold and J. Priest, “Dietary Chromium Tripicolinate Supplementation Reduces Glucose Concentrations and Improves Glucose Tolerance in Normal-Weight Cats,” Journal of Feline Medicine and Surgery, Vol. 4, No. 1, 2002, pp. 13-25. doi:10.1053/jfms.2001.0157
[22]	A. Urmila Shinde, G. Sharma, Y. J. Xu, N. S. Dhalla and R. K. Goyal, “Anti-Diabetic Activity and Mechanism of Action of Chromium Chloride,” Experimental and Clinical Endocrinology & Diabetes, Vol. 112, No. 5, 2004, pp. 248-252. doi:10.1055/s-2004-817971
[23]	X. Guan, et al., “High Chromium Yeast Supplementation Improves Glucose Tolerance in Pigs by Decreasing Hepatic Extraction of Insulin,” Journal of Nutrition, Vol. 130, No. 5, 2000, pp. 1274-1279.
[24]	B. Bahadori, S. Wallner, H. Schneider, T. C. Wascher and H. Toplak, “Effect of Chromium Yeast and Chromium Picolinate on Body Composition of Obese, Non-Diabetic Patients during and after a Formula Diet,” Acta Medica Austriaca, Vol. 24, No. 5, 1997, pp. 185-187.
[25]	D. M. Stearns, J. J. Belbruno and K. E. Wetterhahn, “A Prediction of Chromium (III) Accumulation in Humans from Chromium Dietary Supplements,” FASEB Journal, Vol. 9, No. 15, 1995, pp. 1650-1657.
[26]	Australian Bureau of Statistics, How Australians Measure Up,” Publication No. 4359, Canberra, 1998.
[27]	A. Shaheen, A. Magnusson, A. Khan, K. Ali and A. Hussain, “In Bangladesh, Overweight Individuals Have Fewer Symptoms of Depression Than Non Overweight Individuals Obesity,” Obesity, Vol. 18, No. 6, 2010, pp. 11431145. doi:10.1038/oby.2009.332
[28]	A. Must, et al., “The Disease Burden Associated with Overweight and Obesity,” JAMA, Vol. 282, No. 16, 1999, pp. 1523-1529. doi:10.1001/jama.282.16.1523
[29]	P. W. Castelli, “Concerning the Possibility of a Nut,” Archives of Internal Medicine, Vol. 152, No. 7, 1992, pp. 1371-1372. doi:10.1001/archinte.1992.00400190013003
[30]	C. V. Felton, D. Crook, M. J. Davies and M. F. Oliver, “Dietary Polyunsaturated Fatty Acids and Composition of Human Aortic Plaques,” Lancet, Vol. 344, No. 8931, 1994, pp. 1195-1196. doi:10.1016/S0140-6736(94)90511-8
[31]	K. He, L. Zhao, M. L. Daviglus, A. R. Dyer, L. V. Horn, D. Garside, L. Zhu, D. Guo, Y. Wu, B. Zhou and J. Stamler for the INTERMAP Cooperative Research Group, “Association of Monosodium Glutamate Intake with Overweight in Chinese Adults: The INTERMAP Study,” Obesity , Vol. 16, No. 8, 2008, pp. 1875-1880. doi:10.1038/oby.2008.274